SCHEMBL24318137

SCHEMBL24318137

c1ccc(-c2nc(-c3ccc(-c4ccc(-c5ccc6oc7cc8oc9ccccc9c8cc7c6c5)cc4)cc3)nc(-c3ccccc3-c3ccccc3)n2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 3/20 0.42
PLA2G4A P47712 3/20 0.42
MAOA P21397 1/20 0.38
ALDH1A1 P00352 4/20 0.38
MAPT P10636 3/20 0.38
KDM4E B2RXH2 3/20 0.38
HPGD P15428 3/20 0.38
AHR P35869 1/20 0.38
MEN1 O00255 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
KMT2A Q03164 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
PLA2G10 O15496 1/20 0.38
PIM1 P11309 1/20 0.38
CSNK2A2 P19784 1/20 0.38
CSNK2B P67870 1/20 0.38
PIM3 Q86V86 1/20 0.38
PIM2 Q9P1W9 1/20 0.38
CHEK2 O96017 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24318140 1.00 PLA2G2A (0.42) PLA2G2APLA2G4AMAOAALDH1A1MAPT
SCHEMBL21784513 0.96 PLA2G2A (0.42) PLA2G2APLA2G4AMAOAALDH1A1MAPT
SCHEMBL24318141 0.96 PLA2G2A (0.42) PLA2G2APLA2G4AMAOAALDH1A1MAPT
SCHEMBL24318045 0.96 PLA2G2A (0.43) PLA2G2APLA2G4AALDH1A1MAPTKDM4E
SCHEMBL24318110 0.96 PLA2G2A (0.43) PLA2G2APLA2G4AALDH1A1MAPTKDM4E
SCHEMBL24318026 0.96 PLA2G2A (0.43) PLA2G2APLA2G4AALDH1A1MAPTKDM4E
SCHEMBL24318020 0.96 PLA2G2A (0.43) PLA2G2APLA2G4AALDH1A1MAPTKDM4E
SCHEMBL21784662 0.95 PLA2G2A (0.41) PLA2G2APLA2G4AALDH1A1MAPTKDM4E
SCHEMBL21784663 0.94 PLA2G2A (0.42) PLA2G2APLA2G4AALDH1A1MAPTKDM4E
SCHEMBL23027480 0.94 PLA2G2A (0.44) PLA2G2APLA2G4AALDH1A1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220109115-A1 POLYCYCLIC COMPOUND, AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE POLYCYCLIC COMPOUND IDEMITSU KOSAN CO.,LTD. (JP) 2022-04-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220109115-A1 POLYCYCLIC COMPOUND, AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE POLYCYCLIC COMPOUND ODC1, OTC, PKD1 PLA2G2A 4538/4885PLA2G4A 4679/4885MAOA 355/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.